NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in thousands, except per share data)
(1) Business and Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Certain reclassifications of prior year amounts have been made to conform to the current year presentation. Subsequent events have been evaluated through the date these financial statements were issued. Additionally, the consolidated financial statements should be read in conjunction with Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations, included in this Quarterly Report on Form 10-Q. Operating results for the quarter and the first two quarters ended
December 30, 2018
are not necessarily indicative of the results that may be expected for the year ending
June 30, 2019
. The consolidated balance sheet at
July 1, 2018
has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States ("GAAP") for complete financial statements. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended
July 1, 2018
.
The Company reports fiscal years on a 52-53 week year (5-4-4 basis) ending on the Sunday closest to June 30.
Pending Acquisition of the Company
On December 11, 2018, Sparton Corporation (the "Company" or "Sparton") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Striker Parent 2018, LLC ("Parent"), a Delaware limited liability company and affiliate of Cerberus Capital Management, L.P. ("Cerberus"), and Striker Merger Sub 2018, Inc. ("Merger Sub"), an Ohio corporation and a wholly owned subsidiary of Parent. Upon the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will be merged with and into the Company (the "Merger") with the Company surviving the Merger as a wholly owned subsidiary of Parent.
At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value
$1.25
per share, of the Company (each, a "Share") (other than (i) Shares that immediately prior to the Effective Time are owned by Parent, Merger Sub or any other wholly owned subsidiary of Parent or owned by the Company or any wholly owned subsidiary of the Company (including as treasury stock) and (ii) Shares that are held by any record holder who is entitled to demand and properly demands payment of the fair cash value of such Shares as a dissenting shareholder pursuant to, and who complies in all respects with, the provisions of Section 1701.85 of the Ohio General Corporation Law) will be canceled and converted into the right to receive
$18.50
per Share in cash, without interest.
Consummation of the Merger is subject to the satisfaction or (to the extent permitted by law) waiver of specified closing conditions, including (i) the adoption of the Merger Agreement by the affirmative vote of the holders of at least two-thirds of all the outstanding Shares entitled to vote thereon at a special meeting of the Company's shareholders (the "Shareholders Meeting") to be held on March 1, 2019, as more fully described in the proxy statement of the Company, filed with the SEC on January 23, 2019 (the "Proxy Statement"), (ii) the absence of any law, executive order, ruling, injunction or other order ("Orders") that restrains, enjoins or otherwise prohibits the consummation of the Merger (the "No Order Condition"), (iii) the expiration or early termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act") which expired on January 22, 2019, (such condition, the "HSR Act Condition"), (iv) any agreement with a governmental authority not to consummate the Merger, which agreement shall have been entered into with the prior written consent of both the Company and Parent, shall have expired or been terminated (the "Governmental Authority Agreement Condition") and (v) other customary closing conditions, including the accuracy of each party's representations and warranties and each party's compliance with its covenants and agreements contained in the Merger Agreement (subject in the case of this clause (v) to certain qualifications as to materiality). Consummation of the Merger is not subject to Parent obtaining any financing for or related to the transactions contemplated by the Merger Agreement.
The Company and Parent have agreed to cooperate with each other and use their respective reasonable best efforts to take or cause to be taken all actions, and do or cause to be done all things, reasonably necessary and proper on their part under the Merger and applicable law to consummate and make effective the Merger and the other transactions contemplated by the Merger Agreement as soon as practicable, including preparing and filing as promptly as practicable all documentation to effect all necessary notices, reports and other filings and to obtain as promptly as practicable all consents, registrations, approvals, permits and authorizations necessary or advisable to be obtained from any third party and/or any governmental authority in
order to consummate the Merger or any of the other transactions contemplated by the Merger Agreement. Parent is not required as part of its reasonable best efforts obligation to divest any assets or businesses or engage in any other form of remediation or mitigation action (including holding assets or businesses separate or altering or restricting its business practices in any way), except for, if requested by a governmental authority, any non-sonobuoy-related assets, that individually or in the aggregate, are not material in any respect to the Company and its subsidiaries.
The Merger Agreement includes customary representations and warranties of the Company, Parent and Merger Sub. Many of the representations made by the Company are subject to and qualified by a Material Adverse Effect standard (as defined in the Merger Agreement). The Company, Parent, and Merger Sub have also made certain covenants in the Merger Agreement, including (i) covenants by the Company regarding the operation of its business and that of its subsidiaries prior to the Effective Time, (ii) a customary non-solicitation covenant prohibiting the Company from soliciting, providing non-public information in response to, or entering into discussions or negotiations with respect to, proposals relating to alternative business combination transactions, except as permitted under the Merger Agreement, (iii) a financing covenant by Parent and Merger Sub to take all actions necessary, proper and advisable to obtain Parent's equity financing pursuant to an equity commitment letter between Parent and an affiliate of Cerberus under which such affiliate has committed to acquire securities of Parent in connection with funding Parent's obligations contemplated by the Merger Agreement, and (iv) a customary covenant in which the Company has agreed to use, and to cause its subsidiaries to use, commercially reasonable efforts to provide the cooperation reasonably requested by Parent or Merger Sub to assist Parent and Merger Sub in obtaining debt financing in connection with the Merger.
The Merger Agreement may be terminated by each of the Company and Parent under certain circumstances, including (i) by either the Company or Parent if the Merger is not consummated by May 11, 2019 (subject to an extension to June 11, 2019 at the election of either Parent or the Company if (A) any of the No Order Condition (solely with respect to Orders entered pursuant to the HSR Act or any other applicable antitrust or competition law), the HSR Condition or the Governmental Authority Agreement Condition have not been satisfied by May 11, 2019 or (B) the Shareholders Meeting has not been called and held prior to May 11, 2019) (such date, as may be extended, the "Termination Date") or (ii) by Parent if, following the date of the Merger Agreement, the Company, any of its subsidiaries or ERAPSCO, a joint venture between subsidiaries of Ultra Electronics Holdings plc ("Ultra") and the Company ("ERAPSCO"), are suspended, debarred, excluded or proposed for debarment from doing business with any governmental entity or are declared non-responsible or ineligible for contracting with any governmental entity, subject to a cure period ending on the earlier of (A) sixty (
60
) days after Parent notifies the Company of its intent to so terminate and (B) the Termination Date.
The Merger Agreement provides for certain other termination rights for both the Company and Parent, and further provides that, upon termination of the Merger Agreement under certain specified circumstances, (i) the Company will be required to (A) reimburse certain of Parent's expenses up to a maximum of
$4,750
(the "Expenses") or (B) pay Parent a termination fee of
$7,500
(net of any Expenses previously paid by the Company) or (ii) Parent will be required to pay the Company a termination fee of
$9,250
(the "Parent Termination Fee"). Under the terms of a limited guarantee entered into by the Company and an affiliate of Cerberus (the "Limited Guarantee"), such affiliate of Cerberus has, subject to the terms of the Limited Guarantee, guaranteed Parent's obligation to, among other things, pay the Parent Termination Fee.
The Company has called a special meeting on March 1, 2019, of holders of shares of common stock of the Company, at which time it is expected that the shareholders of record as of January 18, 2019, the record date for the special meeting, will vote on adoption of the Merger Agreement and the other related matters as described in the Proxy Statement.
Q-125A Sonobuoy Bid Process
On July 9, 2018, the Company announced the filing of a bid protest by ERAPSCO with the United States Government Accountability Office ("GAO") challenging the competitive range exclusion of ERAPSCO under the United States Navy Solicitation No. N00019-19-R-0002 for the GFY 19-23 AN/SSQ-125A (the “Q-125A”) production sonobuoy. The protest challenged, on a number of bases, the United States Navy's (the "Navy") decision to exclude ERAPSCO from the solicitation process and requested that GAO restore ERAPSCO's ability to participate in the process. On August 30, 2018, the Navy issued a notice that it had taken corrective action to reopen the competitive range regarding the Q-125A production sonobuoy and include ERAPSCO in that competitive range. This corrective action allows ERAPSCO to again participate in the bid process. As a result of the Navy’s decision to restore ERAPSCO’s ability to participate in the bid process, the GAO dismissed the protest on September 4, 2018.
(2) Revenue Recognition
Effective July 2, 2018, the Company adopted Accounting Standards Codification 606, “Revenue from Contracts with Customers” (“ASC 606”) using the modified retrospective method. As a result, the cumulative effect of adopting ASC 606 on contracts that were open on the date of adoption was recognized as an adjustment to the opening balance sheet at July 2, 2018. The Company did not restate prior period information in its Consolidated Balance Sheet, Consolidated Statement of Operations or Consolidated Statement of Cash Flows.
Sparton's customers typically engage the Company to provide distinct products and services within the Company's
two
reportable segments. In its Manufacturing and Design Services ("MDS") segment, the Company performs services that include contract design, manufacturing, and aftermarket repair. In its Engineered Components & Products ("ECP") segment, the Company provides products and services including design, development and production of proprietary products for domestic and foreign defense markets as well as for commercial needs. The Company considers contracts to exist once (i) the parties have approved the contract and have committed to perform their respective rights and obligations under the contract, (ii) the commitment of goods or services to be transferred has been established, (iii) the payment terms have been established, (iv) the Company has determined the contract has commercial substance, and (v) the Company has determined collectability of substantially all due consideration. Sparton treats contracts with similar characteristics as a portfolio when the results are not materially different from treating contracts individually. The contract price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.
Performance Obligations
Performance obligations are typically satisfied when or as products are shipped to customers. In certain contracts, transfer of control is recognized prior to shipment if the contract meets the requirements of a bill-and-hold arrangement or if the contract restricts Sparton’s use of the products, thereby eliminating the ability to obtain a benefit from the products outside the customer contract. Service based performance obligations are considered satisfied as services are rendered based on costs incurred. The amount of consideration the Company expects to receive is allocated on the basis of each performance obligation’s selling price, including the effect of variable consideration to the extent that revenue would likely not be reversed. The primary method used to estimate the standalone selling price is the contracted or list price. Typical payment terms are
30 days
from invoicing and, in certain agreements, the Company receives progress based payments and deposits in advance of its satisfaction of performance obligations. The Company's warranties are assurance type which are not considered performance obligations and refund or return obligations are not material. The amount of the transaction price allocated to wholly unsatisfied (or partially unsatisfied) performance obligations is represented by the Company's backlog. Of the
$298,000
of backlog at December 30, 2018,
$43,000
is expected to be recognized as revenue beyond the next 12 months.
In its application of practical expedients, under ASC 606, the Company (i) treats contracts with similar characteristics as a portfolio, (ii) excludes implied financing costs from variable consideration, (iii) records service revenue based on its right to invoice, (iv) expenses the incremental cost of obtaining a contract for contracts less than twelve months, (v) excludes taxes collected on behalf of a government authority related to its revenue generating transactions from its calculation of transaction price, and (vi) accrues for expected shipping and handling expenses that are expected to be incurred after control is transferred to customers.
The net impact of adoption of ASC 606 on the Company's opening balance sheet as of July 2, 2018 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Before Adoption of ASC 606
|
|
Effect of adoption
|
|
After adoption of ASC 606
|
Assets:
|
|
|
|
|
|
Accounts receivable, net of allowance for doubtful accounts
|
$
|
60,454
|
|
|
$
|
(7,777
|
)
|
|
$
|
52,677
|
|
Inventories and cost of contracts in progress, net
|
72,406
|
|
|
9,801
|
|
|
82,207
|
|
Prepaid expenses and other current assets
|
3,944
|
|
|
7,390
|
|
|
11,334
|
|
Deferred income taxes
|
17,646
|
|
|
134
|
|
|
17,780
|
|
Liabilities:
|
|
|
|
|
|
Performance based payments on customer contracts
|
3,868
|
|
|
9,893
|
|
|
13,761
|
|
Shareholders' equity:
|
|
|
|
|
|
Retained earnings
|
44,713
|
|
|
(345
|
)
|
|
44,368
|
|
Progress payments from customers related to inventory purchases now are reflected as a liability rather than as a reduction of inventory and unbilled accounts receivable now are classified within prepaid expenses and other current assets rather than within accounts receivable. The net impact to retained earnings as a result of the adoption of ASC 606 was a decrease of
$345
.
Contract Assets and Contract Liabilities
Contract assets consist of the Company's right to consideration for work performed or performance obligations completed which have not yet billed. Contract assets are invoiced and considered accounts receivable when the right to consideration no longer has any further contractual conditions. Contract liabilities consist of customer advances or progress payments for which the Company has not transferred goods or services to its customers. The Company expects to transfer all underlying goods and services to the customer within
12 months
of establishing a contract liability.
Contract assets and contract liabilities from revenue contracts with customers consist of the following amounts within the Company's respective consolidated balance sheet captions as of December 30, 2018 and the opening balance sheet date of July 2, 2018:
|
|
|
|
|
|
|
|
|
|
As of
|
|
December 30,
2018
|
|
July 2,
2018
|
Contract assets:
|
|
|
|
Prepaid expenses and current assets
|
$
|
3,149
|
|
|
$
|
6,891
|
|
Contract liabilities:
|
|
|
|
Performance based payments on customer contracts
|
8,827
|
|
|
13,761
|
|
Advances from customers
|
5,764
|
|
|
5,899
|
|
Revenue of
$15,536
that was included in the contract liabilities at July 2, 2018 was recognized in the first two fiscal quarters ended
December 30, 2018
.
Changes in the contract assets and contract liabilities account balances were attributed to regular business activity.
The following tables summarize the impact of adopting ASC 606 on the Company's unaudited condensed consolidated financial statements at
December 30, 2018
and for the second quarter ended and the first two fiscal quarters ended
December 30, 2018
:
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Balance Sheet
|
December 30, 2018
|
|
As reported
|
|
Net effect of adoption of ASC 606
|
|
Balances without adoption of ASC 606
|
Assets:
|
|
|
|
|
|
Inventories and cost of contracts in progress, net
|
$
|
86,295
|
|
|
$
|
(837
|
)
|
|
$
|
85,458
|
|
Prepaid expenses and other current assets
|
8,131
|
|
|
452
|
|
|
8,583
|
|
Total current assets
|
143,091
|
|
|
(385
|
)
|
|
142,706
|
|
Deferred income taxes
|
14,786
|
|
|
(134
|
)
|
|
14,652
|
|
Total assets
|
224,722
|
|
|
(519
|
)
|
|
224,203
|
|
Liabilities and Shareholders’ Equity:
|
|
|
|
|
|
Performance based payments on customer contracts
|
8,827
|
|
|
(1,316
|
)
|
|
7,511
|
|
Other accrued expenses
|
7,805
|
|
|
95
|
|
|
7,900
|
|
Total current liabilities
|
144,005
|
|
|
(1,221
|
)
|
|
142,784
|
|
Total liabilities
|
149,236
|
|
|
(1,221
|
)
|
|
148,015
|
|
Retained earnings
|
46,497
|
|
|
702
|
|
|
47,199
|
|
Total shareholders’ equity
|
75,486
|
|
|
702
|
|
|
76,188
|
|
Total liabilities and shareholders’ equity
|
224,722
|
|
|
(519
|
)
|
|
224,203
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Statements of Operations
|
For the Second Quarter of Fiscal Year 2019
|
|
As reported
|
|
Net effect of adoption of ASC 606
|
|
Excluding the effect of adoption of ASC 606
|
Net sales
|
$
|
105,248
|
|
|
$
|
(1,381
|
)
|
|
$
|
103,867
|
|
Cost of goods sold
|
82,176
|
|
|
(754
|
)
|
|
81,422
|
|
Gross profit
|
23,072
|
|
|
(627
|
)
|
|
22,445
|
|
Operating income
|
5,255
|
|
|
(627
|
)
|
|
4,628
|
|
Income before income taxes
|
3,408
|
|
|
(627
|
)
|
|
2,781
|
|
Income taxes
|
1,491
|
|
|
(132
|
)
|
|
1,359
|
|
Net income
|
$
|
1,917
|
|
|
$
|
(495
|
)
|
|
$
|
1,422
|
|
|
|
|
|
|
|
|
For the First Two Quarters of Fiscal Year 2019
|
|
As reported
|
|
Net effect of adoption of ASC 606
|
|
Excluding the effect of adoption of ASC 606
|
Net sales
|
$
|
194,710
|
|
|
$
|
92
|
|
|
$
|
194,802
|
|
Cost of goods sold
|
153,999
|
|
|
(360
|
)
|
|
153,639
|
|
Gross profit
|
40,711
|
|
|
452
|
|
|
41,163
|
|
Operating income
|
7,505
|
|
|
452
|
|
|
7,957
|
|
Income before income taxes
|
3,695
|
|
|
452
|
|
|
4,147
|
|
Income taxes
|
1,566
|
|
|
95
|
|
|
1,661
|
|
Net income
|
$
|
2,129
|
|
|
$
|
357
|
|
|
$
|
2,486
|
|
Revenue by Category
The following table reflects the Company's revenue disaggregated by major end-use market for the periods ended:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Second Quarter of Fiscal Years
|
|
For the First Two Quarters of Fiscal Years
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
ECP Segment
|
|
|
|
|
|
|
|
U.S. sonobuoy
|
$
|
26,178
|
|
|
$
|
29,026
|
|
|
$
|
47,021
|
|
|
$
|
45,993
|
|
Foreign sonobuoy
|
7,626
|
|
|
4,064
|
|
|
10,750
|
|
|
9,672
|
|
Engineering services
|
1,719
|
|
|
1,057
|
|
|
3,907
|
|
|
1,606
|
|
Rugged electronics
|
7,460
|
|
|
8,289
|
|
|
14,617
|
|
|
15,557
|
|
Total ECP Segment
|
42,983
|
|
|
42,436
|
|
|
76,295
|
|
|
72,828
|
|
MDS Segment
|
|
|
|
|
|
|
|
Manufacturing
|
58,177
|
|
|
51,269
|
|
|
110,084
|
|
|
98,961
|
|
Engineering services
|
3,452
|
|
|
3,271
|
|
|
7,057
|
|
|
7,540
|
|
Other
|
636
|
|
|
843
|
|
|
1,274
|
|
|
1,253
|
|
Total MDS Segment
|
62,265
|
|
|
55,383
|
|
|
118,415
|
|
|
107,754
|
|
Total net sales
|
$
|
105,248
|
|
|
$
|
97,819
|
|
|
$
|
194,710
|
|
|
$
|
180,582
|
|
(3) Inventories and Cost of Contracts in Progress, net
The following are the major classifications of inventory, net of interim billings:
|
|
|
|
|
|
|
|
|
|
December 30,
2018
|
|
July 1,
2018
|
Raw materials
|
$
|
62,563
|
|
|
$
|
56,088
|
|
Work in process
|
15,307
|
|
|
16,138
|
|
Finished goods
|
8,425
|
|
|
8,784
|
|
Total inventory and cost of contracts in progress, gross
|
86,295
|
|
|
81,010
|
|
Inventory to which the U.S. government has title due to interim billings
|
—
|
|
|
(8,604
|
)
|
Total inventory and cost of contracts in progress, net
|
$
|
86,295
|
|
|
$
|
72,406
|
|
In accordance with the application of ASC 606, progress payments from customers related to inventory purchases are reflected as liabilities rather than as a reduction of net inventories as presented on July 1, 2018.
(4) Property, Plant and Equipment, net
Property, plant and equipment, net consists of the following:
|
|
|
|
|
|
|
|
|
|
December 30,
2018
|
|
July 1,
2018
|
Land and land improvements
|
$
|
1,461
|
|
|
$
|
1,439
|
|
Buildings and building improvements
|
28,215
|
|
|
28,160
|
|
Machinery and equipment
|
54,433
|
|
|
53,250
|
|
Construction in progress
|
2,084
|
|
|
1,391
|
|
Total property, plant and equipment
|
86,193
|
|
|
84,240
|
|
Less accumulated depreciation
|
(54,224
|
)
|
|
(51,450
|
)
|
Property, plant and equipment, net
|
$
|
31,969
|
|
|
$
|
32,790
|
|
(5) Other Intangible Assets
The components of other intangible assets, net consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Carrying Value at
July 1, 2018
|
|
Amortization
|
|
Net Carrying Value at
December 30, 2018
|
Non-compete agreements
|
$
|
680
|
|
|
$
|
(321
|
)
|
|
$
|
359
|
|
Customer relationships
|
19,061
|
|
|
(2,831
|
)
|
|
16,230
|
|
Trademarks/Tradenames
|
1,059
|
|
|
(81
|
)
|
|
978
|
|
Unpatented technology and patents
|
308
|
|
|
(78
|
)
|
|
230
|
|
Other intangible assets, net
|
$
|
21,108
|
|
|
$
|
(3,311
|
)
|
|
$
|
17,797
|
|
(6) Debt
On September 11, 2014, the Company entered into a revolving line-of-credit facility with a group of banks (the “Credit Facility”) which expires on September 11, 2019. On May 3, 2018, the Company entered into Amendment No.5 ("Amendment 5") to the Credit Facility. Under the terms of Amendment 5, (i) the revolving credit facility was reduced from
$125,000
to
$120,000
, (ii) the Company's permitted Total Funded Debt to EBITDA Ratio, as defined, was increased to
4.5
x for the fiscal quarters ended April 1, 2018 and July 1, 2018, and beginning with the fiscal quarters ended September 30, 2018 and thereafter the Company's permitted Total Funded Debt to EBITDA Ratio was decreased to
3.0
x, and (iii) the interest rates on the revolving line of credit were increased, at the Company's option, to either LIBOR, plus
3.50%
to
4.50%
, or the bank’s base rate, as defined, plus
2.50%
to
3.50%
. In addition, Amendment 5 also fixed the commitment fees on the unused portion of the Credit Facility at
0.50%
.
The Credit Facility is secured by substantially all assets of the Company and its subsidiaries. As of
December 30, 2018
, the Company had
$49,821
available under the Credit Facility, with current borrowings under the facility of
$64,100
, outstanding letters of credit of
$6,047
and capital leases of
$32
.
As of
December 30, 2018
, outstanding borrowings under the Credit Facility will bear interest, at the Company’s option, at either LIBOR, fixed for interest periods of one, two, three or six month periods, plus
3.50%
to
4.50%
, or at the bank’s base rate, as defined, plus
2.50%
to
3.50%
, based upon the Company’s Total Funded Debt/EBITDA Ratio, as defined. The effective interest rate on outstanding borrowings under the Credit Facility was
6.08%
at
December 30, 2018
.
The Credit Facility includes representations, covenants and events of default that are customary for financing transactions of this nature. The Company was compliant with all such covenants at
December 30, 2018
.
As a result of the pending acquisition of the Company and the full repayment of the Credit Facility upon the effective date of the Merger, the Credit Facility has been classified as a current liability on the Company's consolidated balance sheet as of December 30, 2018.
(7) Income Taxes
On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (“Tax Act”) was signed into law. The Tax Act made significant changes to U.S. tax laws including, but not limited to, lowering the federal income tax rate for U.S. corporations from a maximum of
35%
to a fixed
21%
, revising certain corporate income tax deductions, implementing a territorial tax system and imposing a repatriation tax on unrepatriated earnings of foreign subsidiaries. The new federal tax rate was effective January 1, 2018. For corporations that report on a fiscal year basis, the Tax Act required the use of a full-year blended income tax rate based on the new and old rates.
The Company's effective income tax rate for interim periods was determined based on the Company's estimated annual effective tax rate for the applicable year using the federal statutory income tax rate, permanent tax differences, foreign income and state income tax rates, as well as the impact of federal, foreign and state tax deductions and credits.
The Company's estimated annual effective income tax rate for the fiscal year 2019 was determined to be
21%
. Income tax expense for the second quarter of fiscal 2019 included a
$1,675
discrete tax expense item related the write off of a deferred tax asset on certain transaction costs associated with the Company's pending Merger and an
$887
discrete tax credit item related to the completion of the Company's income tax returns for fiscal year 2018.
For the first quarter of fiscal year
2018
, the Company used an effective income tax rate of
35%
as the Tax Act had not yet been enacted. Subsequent to the Tax Act, the Company used an annual effective income tax rate of
28%
for fiscal year
2018
, exclusive of any discrete tax events. During the second quarter of fiscal year 2018, as a result of the Tax Act, the Company
recorded income tax expense of
$10,100
for a provisional reduction in its net deferred tax assets,
$400
for a provisional liability related to unrepatriated earnings and profits of foreign subsidiaries and
$307
to adjust the tax benefit recorded in the first quarter of fiscal year
2018
. In addition to the discrete income tax events of the Tax Acts in the second quarter of fiscal year
2018
, the Company recognized a discrete income tax benefit of
$118
during the second quarter of fiscal year
2018
as a result of a return to provision true-up when filing its fiscal year
2017
tax return as well as amending certain tax returns from earlier tax years.
In December 2017, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 118 which addresses how a company recognizes provisional amounts when a company does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete the accounting for certain tax effects of the Tax Act and provides for a one-year measurement period. The ultimate impact of the Tax Act may differ from the provisional amounts the Company has recorded due to additional analysis, changes in interpretations and assumptions the Company has made and additional regulatory guidance that may be issued. The accounting was completed before the end of the measurement period on
December 22, 2018
.
(8) Defined Benefit Pension Plan
The Company has a frozen defined benefit pension plan. The Company recorded net periodic pension expense of
$5
and net periodic pension income of
$6
for the second quarter of fiscal years
2019
and
2018
, respectively. Net periodic pension expense was
$7
and
$13
for the first two quarters of fiscal years
2019
and
2018
, respectively.
No
contributions were made to the pension plan during either of the first two quarters of fiscal years
2019
and
2018
.
(9) Commitments and Contingencies
The Company is a party to an environmental remediation matter in Albuquerque, New Mexico ("Coors Road"). As of
December 30, 2018
and
July 1, 2018
, Sparton had accrued
$5,240
and
$5,508
respectively, as its estimate of the remaining minimum future discounted financial liability regarding this matter, of which
$642
and
$642
, respectively, was classified as a current liability and included on its consolidated balance sheets in other accrued expenses. As of
December 30, 2018
and
July 1, 2018
, the Company had accrued
$1,606
, in relation to expected reimbursements from the Department of Energy, which are included in other non-current assets on the consolidated balance sheets and are considered collectible.
At the end of each fiscal year, the Company is required to certify compliance with the United States Environmental Protection Agency's (“EPA”) financial assurance requirements. If the Company is not in compliance, funds for environmental remediation costs must be set aside. As a result of the
$9,197
of income tax expense related to the tax law changes from the Tax Act that the Company recorded in fiscal year 2018, the Company was not in compliance with such financial assurance requirements at the end of fiscal year 2018. In October 2018, the Company established the Sparton Corporation Standby Financial Assurance Trust and issued a standby letter of credit in the amount of
$2,512
related to the Coors Road environmental remediation matter. The trust was established to alternately meet the EPA’s financial assurance requirements.
See the Company’s Annual Report on Form 10-K for the fiscal year ended
July 1, 2018
for further information regarding the Company's environmental matters.
In addition to the foregoing, from time to time, the Company is involved in various legal proceedings relating to claims arising in the ordinary course of business.
The Company and the members of its board of directors were named as defendants in
four
federal securities class actions purportedly brought on behalf of all holders of the Company’s common stock challenging the merger (the "Sparton/Ultra Merger") contemplated by the now terminated Agreement and Plan of Merger, dated as of July 7, 2017 (the "Sparton/Ultra Merger Agreement"), by and among the Company, Ultra and Ultra Electronics Aneira, Inc. The lawsuits generally sought, among other things, to enjoin the defendants from proceeding with the shareholder vote on the Sparton/Ultra Merger Agreement at the special meeting or consummating the Sparton/Ultra Merger unless and until the Company disclosed the allegedly omitted information. The complaints also sought damages allegedly suffered by the plaintiffs as a result of the asserted omissions, as well as related attorneys’ fees and expenses. After discussions with counsel for the plaintiffs, the Company included certain additional disclosures in the proxy statement soliciting shareholder approval of the Sparton/Ultra Merger Agreement. The Company believed the demands and complaints were without merit, there were substantial legal and factual defenses to the claims asserted, and the proxy statement disclosed all material information prior to the inclusion of the additional disclosures. The Company made the additional disclosures to avoid the expense and burden of litigation. On September 1, 2017, the court dismissed the lawsuits with prejudice with respect to the lead plaintiffs in the lawsuits and without prejudice as to all other shareholders. During the second quarter of fiscal year 2018, the Company and the plaintiffs agreed to settle the claim for
$200
.
The members of the Company's board of directors were named as defendants in another class action suit filed in the United States District Court for the Northern District of Ohio on October 24, 2017, purportedly brought on behalf of all holders of the Company's common stock. This lawsuit sought damages allegedly suffered by plaintiffs as a result of violations by the members of the board of directors of their fiduciary duties. As a result of the termination of the Sparton/Ultra Merger Agreement, on March 16, 2018, the parties to the lawsuit stipulated to a dismissal of the lawsuit without prejudice.
The Company was party to a dispute regarding a health claim by a former employee and her children (collectively the "plaintiffs") of one of the Company’s former businesses. The plaintiffs sought monetary damages related to their medical care and treatment, pain and suffering, and lost earnings. In fiscal year 2018, the Company accrued
$635
for potential insurance deductibles and legal fees associated with this claim. In August 2018, a
$5,500
settlement was reached between the plaintiffs, the Company, and the Company’s insurer, where the Company would pay
$500
in settlement costs in excess of its
$5,000
insurance coverage and
$500
in insurance deductibles. The Company recorded this settlement in fiscal year 2018, and also recorded
$594
of legal fees related to this dispute. The settlement was paid in full in the second quarter of fiscal 2019.
The Company was the plaintiff in a lawsuit against the previous owner and other shareholders of Hunter Technology Corporation (“Hunter”), a business acquired by the Company, for breaches of the acquisition agreement and fraud. In June 2018, the Court ruled against the Company, and the Company was required to reimburse the defendant’s legal fees of
$484
. The Company also incurred
$115
of legal fees related to this matter. The Company recorded the liability in the fourth quarter of fiscal year 2018, and expensed its related legal fees during fiscal year 2018. The Company is also involved in a dispute between a predecessor company of Hunter and the California State Board of Equalization (“SBOE”) regarding unpaid taxes for which the Company is liable. In the fourth quarter of fiscal year 2018, the Company accrued
$500
as an estimated settlement of this liability. This dispute remains in negotiations with the SBOE and the Company.
The Company is involved in a matter with Goodrich Corporation (“Goodrich”) in which Goodrich has alleged that the Company owes indemnification to Goodrich under an agreement as a result of damages suffered by Goodrich in a lawsuit that Goodrich settled. The Company has disputed the indemnification claim and Goodrich has requested the parties mediate the dispute or move to trial. This dispute is covered by insurance, subject to normal reservation of rights by the insurance company, and the Company believes that a settlement, if any, would likely be within the Company’s coverage. No amounts have been accrued as it is not probable that a loss has been incurred.
The Company is not currently a party to any other legal proceedings, the adverse outcome of which, individually or in the aggregate, is expected to have a material adverse effect on the Company's business, financial condition or results of operations.
The Company is subject to audits by certain federal government agencies, including the Defense Contract Audit Agency and the Defense Contract Management Agency. The agencies audit and evaluate government contracts and government contractors’ administrative processes and systems. These agencies review the Company’s performance on contracts, pricing practices, cost structure, financial capability and compliance with applicable laws, regulations and standards. They also review the adequacy of the Company’s internal control systems and policies, including the Company’s purchasing, accounting, estimating, compensation and management information processes and systems. The Company works closely with these agencies to ensure compliance. From time to time, the Company is notified of claims related to noncompliance arising from the audits performed by these agencies. Such claims have historically been subject to actions of remediation and/or financial claims that are typically subject to negotiated settlements. The Company believes that it has appropriate reserves established for outstanding issues and is not aware of any issues of noncompliance that would have a material adverse effect on the Company’s financial position or results of operations.
(10) Stock-Based Compensation
The Company has a long-term incentive plan to offer incentive and non-qualified stock options, stock appreciation rights, restricted stock or restricted stock units, performance awards and other stock-based awards, including grants of shares under the Sparton Corporation 2010 Long-Term Incentive Plan (the “2010 Plan”).
The following table shows stock-based compensation expense by type of share-based award included in the consolidated statements of operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Second Quarter of Fiscal Years
|
|
For the First Two Quarters of Fiscal Years
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
Fair value expense of stock option awards
|
$
|
5
|
|
|
$
|
4
|
|
|
$
|
6
|
|
|
$
|
43
|
|
Restricted stock units
|
55
|
|
|
7
|
|
|
41
|
|
|
178
|
|
Restricted and unrestricted stock
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Total stock-based compensation expense
|
$
|
60
|
|
|
$
|
11
|
|
|
$
|
47
|
|
|
$
|
221
|
|
The following is a summary of activity for the first two quarters of fiscal year
2019
related to the 2010 Plan:
|
|
|
|
|
|
|
|
|
|
|
Stock Options
|
|
Restricted stock units
|
|
Restricted shares
|
Outstanding at July 1, 2018
|
78,249
|
|
|
95,686
|
|
|
—
|
|
Granted
|
—
|
|
|
—
|
|
|
—
|
|
Forfeited
|
(9,780
|
)
|
|
(21,093
|
)
|
|
—
|
|
Outstanding at December 30, 2018
|
68,469
|
|
|
74,593
|
|
|
—
|
|
As of
December 30, 2018
,
56,630
stock options were exercisable, of which
17,120
vested in the first two quarters of fiscal year
2019
.
(11) Earnings Per Share Data
The following table sets forth the computation of basic and diluted net income/(loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Second Quarter of Fiscal Years
|
|
For the First Two Quarters of Fiscal Years
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
Numerator:
|
|
|
|
|
|
|
|
Net income (loss)
|
$
|
1,917
|
|
|
$
|
(8,084
|
)
|
|
$
|
2,129
|
|
|
$
|
(10,068
|
)
|
Less net income allocated to contingently issuable participating securities
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Net income (loss) available to common shareholders
|
$
|
1,917
|
|
|
$
|
(8,084
|
)
|
|
$
|
2,129
|
|
|
$
|
(10,068
|
)
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding – Basic
|
9,834,723
|
|
|
9,834,723
|
|
|
9,834,723
|
|
|
9,845,686
|
|
Dilutive effect of stock options
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Weighted average shares outstanding – Diluted
|
9,834,723
|
|
|
9,834,723
|
|
|
9,834,723
|
|
|
9,845,686
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to common shareholders per share:
|
|
|
|
|
|
|
|
Basic
|
$
|
0.19
|
|
|
$
|
(0.82
|
)
|
|
$
|
0.22
|
|
|
$
|
(1.02
|
)
|
Diluted
|
0.19
|
|
|
(0.82
|
)
|
|
$
|
0.22
|
|
|
$
|
(1.02
|
)
|
There were
no
unvested restricted shares outstanding during the second quarter of fiscal year 2019, the first two quarters of fiscal year 2019, and the second quarter of fiscal year 2018. Net income available to common shareholders was not reduced by allocated earnings associated with unvested restricted shares of
10,963
for the first two quarters of fiscal year
2018
, as the unvested restricted shares did not participate in the net loss for the first two quarters of fiscal year
2018
.
The computation of diluted net income per share for the second quarter of fiscal year 2019 and the first two quarters of fiscal 2019 excluded any potential shares of commons stock issuable upon the exercise of stock options as the option price exercises were in excess of the average share price for the respective periods.
The computation of diluted net loss per share for the second quarter of fiscal year 2018 and the first two quarters of fiscal year 2018 excluded potential shares of common stock issuable upon exercise of stock options totaling
580
and
581
, respectively, as their inclusion would have had an anti-dilutive effect due to the net losses for these periods.
(12) Business Segments
As previously described, the Company has identified
two
reportable segments, MDS and ECP. The Company uses an internal management reporting system, which provides important financial data to evaluate performance and allocate the Company's resources on a segment basis. The Company’s Chief Operating Decision Maker assesses segment performance and allocates resources to each segment individually.
Operating results and certain other financial information about the Company’s
two
reportable segments for the second quarter and first two quarters of fiscal years
2019
and
2018
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Second Quarter of Fiscal Year 2019
|
|
MDS
|
|
ECP
|
|
Unallocated
|
|
Eliminations
|
|
Total
|
Gross sales
|
$
|
65,402
|
|
|
$
|
42,983
|
|
|
$
|
—
|
|
|
$
|
(3,137
|
)
|
|
$
|
105,248
|
|
Gross profit
|
8,855
|
|
|
14,217
|
|
|
—
|
|
|
—
|
|
|
23,072
|
|
Selling and administrative expenses (incl. depreciation)
|
5,758
|
|
|
3,497
|
|
|
5,479
|
|
|
—
|
|
|
14,734
|
|
Internal research and development expenses
|
—
|
|
|
1,442
|
|
|
—
|
|
|
—
|
|
|
1,442
|
|
Depreciation and amortization
|
1,916
|
|
|
485
|
|
|
604
|
|
|
—
|
|
|
3,005
|
|
Operating income
|
1,746
|
|
|
8,988
|
|
|
(5,479
|
)
|
|
—
|
|
|
5,255
|
|
Capital expenditures
|
580
|
|
|
547
|
|
|
175
|
|
|
—
|
|
|
1,302
|
|
Total assets at December 30, 2018
|
154,097
|
|
|
73,521
|
|
|
(2,896
|
)
|
|
—
|
|
|
224,722
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Second Quarter of Fiscal Year 2018
|
|
MDS
|
|
ECP
|
|
Unallocated
|
|
Eliminations
|
|
Total
|
Gross sales
|
$
|
58,353
|
|
|
$
|
42,468
|
|
|
$
|
—
|
|
|
$
|
(3,002
|
)
|
|
$
|
97,819
|
|
Gross profit
|
6,960
|
|
|
14,789
|
|
|
—
|
|
|
—
|
|
|
21,749
|
|
Selling and administrative expenses (incl. depreciation)
|
5,614
|
|
|
3,570
|
|
|
4,890
|
|
|
—
|
|
|
14,074
|
|
Internal research and development expenses
|
—
|
|
|
669
|
|
|
—
|
|
|
—
|
|
|
669
|
|
Depreciation and amortization
|
2,247
|
|
|
535
|
|
|
567
|
|
|
—
|
|
|
3,349
|
|
Operating income (loss)
|
(208
|
)
|
|
10,211
|
|
|
(4,890
|
)
|
|
—
|
|
|
5,113
|
|
Capital expenditures
|
2,210
|
|
|
208
|
|
|
226
|
|
|
—
|
|
|
2,644
|
|
Total assets at July 1, 2018
|
147,860
|
|
|
71,558
|
|
|
12,584
|
|
|
—
|
|
|
232,002
|
|
|
|
|
|
|
|
|
|
|
|
|
For the First Two Quarters of Fiscal Year 2019
|
|
MDS
|
|
ECP
|
|
Unallocated
|
|
Eliminations
|
|
Total
|
Gross sales
|
$
|
124,696
|
|
|
$
|
76,295
|
|
|
$
|
—
|
|
|
$
|
(6,281
|
)
|
|
$
|
194,710
|
|
Gross profit
|
16,064
|
|
|
24,647
|
|
|
—
|
|
|
—
|
|
|
40,711
|
|
Selling and administrative expenses (incl. depreciation)
|
11,302
|
|
|
7,180
|
|
|
8,622
|
|
|
—
|
|
|
27,104
|
|
Internal research and development expenses
|
—
|
|
|
2,791
|
|
|
—
|
|
|
—
|
|
|
2,791
|
|
Depreciation and amortization
|
3,929
|
|
|
963
|
|
|
1,193
|
|
|
—
|
|
|
6,085
|
|
Operating income (loss)
|
2,036
|
|
|
14,091
|
|
|
(8,622
|
)
|
|
—
|
|
|
7,505
|
|
Capital expenditures
|
672
|
|
|
831
|
|
|
450
|
|
|
—
|
|
|
1,953
|
|
|
|
|
|
|
|
|
|
|
|
|
For the First Two Quarters of Fiscal Year 2018
|
|
MDS
|
|
ECP
|
|
Unallocated
|
|
Eliminations
|
|
Total
|
Gross sales
|
$
|
113,661
|
|
|
$
|
72,867
|
|
|
$
|
—
|
|
|
$
|
(5,946
|
)
|
|
$
|
180,582
|
|
Gross profit
|
12,953
|
|
|
24,720
|
|
|
—
|
|
|
—
|
|
|
37,673
|
|
Selling and administrative expenses (incl. depreciation)
|
11,514
|
|
|
7,150
|
|
|
10,615
|
|
|
—
|
|
|
29,279
|
|
Internal research and development expenses
|
—
|
|
|
1,241
|
|
|
—
|
|
|
—
|
|
|
1,241
|
|
Depreciation and amortization
|
4,575
|
|
|
1,096
|
|
|
1,135
|
|
|
—
|
|
|
6,806
|
|
Operating income (loss)
|
(1,693
|
)
|
|
15,645
|
|
|
(10,615
|
)
|
|
—
|
|
|
3,337
|
|
Capital expenditures
|
2,315
|
|
|
395
|
|
|
389
|
|
|
—
|
|
|
3,099
|
|
(13) New Accounting Standards
In February 2016, the FASB issued ASU No. 2016-02 (“ASU 2016-02”),
Leases (Topic 842)
. ASU 2016-02 establishes a right-of-use ("ROU") model that requires a lessee to record a ROU asset and
a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. A modified retrospective transition approach is required for capital leases and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is currently in the process of evaluating the impact of adoption on its consolidated financial statements.
In June 2016, the FASB issued ASU No. 2016-13 ("ASU 2016-13"),
Financial Instruments
—
Credit Losses (Topic 326)
. ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019 and early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its consolidated financial statements.
In January 2017, the FASB issued ASU No. 2017-04 (“ASU 2017-04”),
Simplifying the Test for Goodwill Impairment
. ASU 2017-04 eliminates step 2 from the goodwill impairment test. As amended, the goodwill impairment test will consist of one step comparing the fair value of a reporting unit with its carrying amount. An entity should recognize a goodwill impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. An entity may still perform the optional qualitative assessment for a reporting unit to determine if it is more likely than not that goodwill is impaired. ASU 2017-04 will be effective for fiscal years and interim periods beginning after December 15, 2019. ASU 2017-04 is required to be applied prospectively and early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company is currently in the process of evaluating the impact of adoption on its consolidated financial statements.
In February 2018, the FASB issued ASU 2018-02 (“ASU 2018-02”),
Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.
ASU 2018-02 permits the reclassification of certain “stranded tax effects” resulting from the recent U.S. tax reform from accumulated other comprehensive income to retained earnings. ASU 2018-02 is effective for all entities for fiscal years beginning after December 15, 2018, including interim periods within those years. Entities have the option to record the reclassification either retrospectively to each period in which the income tax effects of tax reform are recognized, or at the beginning of the annual or interim period in which the amendments are adopted. Early adoption is permitted, including adoption in an interim period. The Company is currently in the process of evaluating the impact of adoption on its consolidated financial statements.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following is management’s discussion and analysis of certain significant events affecting Sparton Corporation’s (the “Company” or “Sparton”) results of operations and financial condition during the periods included in the accompanying financial statements. Additional information regarding the Company can be accessed via Sparton’s website at www.sparton.com. Information provided at the website includes, among other items, the Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Quarterly Earnings Releases, News Releases and the Code of Business Conduct and Ethics, as well as various corporate charters and documents.
Pending Acquisition of the Company
On December 11, 2018, the Company entered into an Agreement and Plan of Merger (the "Merger Agreement") with Striker Parent 2018, LLC ("Parent"), a Delaware limited liability company and affiliate of Cerberus Capital Management, L.P., and Striker Merger Sub 2018, Inc. ("Merger Sub"), an Ohio corporation and a wholly owned subsidiary of Parent. Upon the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will be merged with and into the Company (the "Merger") with the Company surviving the Merger as a wholly owned subsidiary of Parent. See Note 1, Business and Basis of Presentation - Pending Acquisition of the Company, of the "Notes to Unaudited Consolidated Financial Statements" in this Quarterly Report on Form 10-Q for a discussion of the pending acquisition of the Company.
Consolidated Results of Operations
Presented below is comparative data and discussions regarding our consolidated results of operations for the second quarter and the first two quarters of fiscal year
2019
compared to the second quarter and the first two quarters of fiscal year
2018
. Results of operations for any period less than one year are not necessarily indicative of results of operations that may be
expected for a full year. The following discussion should be read in conjunction with the Unaudited Consolidated Financial Statements and Notes thereto included in Item 1 of this Quarterly Report on Form 10-Q.
For the Second Quarter of Fiscal Year 2019 compared to the Second Quarter of Fiscal Year 2018
The following table presents selected consolidated statements of operations data (dollars in thousands):
CONSOLIDATED
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Second Quarter of Fiscal Years
|
|
2019
|
|
% of Sales
|
|
2018
|
|
% of Sales
|
Net sales
|
$
|
105,248
|
|
|
100.0
|
%
|
|
$
|
97,819
|
|
|
100.0
|
%
|
Cost of goods sold
|
82,176
|
|
|
78.1
|
|
|
76,070
|
|
|
77.8
|
|
Gross profit
|
23,072
|
|
|
21.9
|
|
|
21,749
|
|
|
22.2
|
|
Selling and administrative expenses
|
14,734
|
|
|
14.0
|
|
|
14,074
|
|
|
14.4
|
|
Internal research and development expenses
|
1,442
|
|
|
1.4
|
|
|
669
|
|
|
0.7
|
|
Amortization of intangible assets
|
1,641
|
|
|
1.5
|
|
|
1,893
|
|
|
1.9
|
|
Operating income
|
5,255
|
|
|
5.0
|
|
|
5,113
|
|
|
5.2
|
|
Other expense, net
|
(1,847
|
)
|
|
(1.8
|
)
|
|
(1,494
|
)
|
|
(1.5
|
)
|
Income before income taxes
|
3,408
|
|
|
3.2
|
|
|
3,619
|
|
|
3.7
|
|
Income taxes
|
1,491
|
|
|
1.4
|
|
|
11,703
|
|
|
12.0
|
|
Net income (loss)
|
$
|
1,917
|
|
|
1.8
|
%
|
|
$
|
(8,084
|
)
|
|
(8.3
|
)%
|
The increase in net sales was the result of a
$6.9 million
sales increase in our MDS segment due to increasing net volume with existing customers, and a
$0.5 million
sales increase in our ECP segment due to increasing revenue for foreign sonobuoys and engineering services. The increase in gross profit was primarily due to improved MDS margins arising from an increase in sales while containing direct labor and overhead spending, partially offset by decreased ECP margins due to increased engineering staff in support of customer programs expected to broaden product offerings. Selling and administrative expense increased $0.7 million in the second quarter of fiscal year 2019 compared to the second quarter of fiscal year 2018 due to increased legal and advisory expenses related to the potential sale of the Company. Internal research and development costs increased over the prior year quarter due to investment in technologies for use in undersea warfare.
On December 22, 2017, the Tax Cuts and Jobs Act of 2017 ("Tax Act") was signed into law. The Tax Act made significant changes to U.S. tax laws including, but not limited to, lowering the federal income tax rate for U.S. corporations from a maximum of
35%
to a fixed
21%
, revising certain corporate income tax deductions, implementing a territorial tax system and imposing a repatriation tax on unrepatriated earnings of foreign subsidiaries. The new tax rate was effective January 1, 2018. For corporations that report on a fiscal year basis, the Tax Act required the use of a full-year blended income tax rate based on the new and old rates.
The Company's effective income tax rate for interim periods was determined based on the Company's estimated annual effective tax rate for the applicable year using the federal statutory income tax rate, permanent tax differences, foreign income and state income tax rates, as well as the impact of federal, foreign and state tax deductions and credits.
The Company's estimated annual effective income tax rate for the fiscal year 2019 was determined to be
21%
. Income tax expense for the second quarter of fiscal 2019 included a
$1.7 million
discrete tax expense item related to the write-off of a deferred tax asset on transaction certain costs associated with the Company's pending Merger and a
$0.9 million
discrete tax credit item related to the completion of the Company's income tax returns for fiscal year 2018.
For the first quarter of fiscal year
2018
, the Company used an effective income tax rate of
35%
as the Tax Act had not yet been enacted. Subsequent to the Tax Act, the Company used an annual effective income tax rate of
28%
for fiscal year
2018
, exclusive of any discrete tax events. During the second quarter of fiscal year 2018, as a result of the Tax Act, the Company recorded income tax expense of
$10.1 million
for a provisional reduction in its net deferred tax assets,
$0.4 million
for a provisional liability related to unrepatriated earnings and profits of foreign subsidiaries and
$0.3 million
to adjust the tax benefit recorded in the first quarter of fiscal year
2018
. In addition to the discrete income tax events of the Tax Acts in the second quarter of fiscal year
2018
, the Company recognized a discrete income tax benefit of
$0.1 million
during the second quarter of fiscal year
2018
as a result of a return to provision true-up when filing its fiscal year
2017
tax return as well as amending certain tax returns from earlier tax years.
Due to the factors described above, the Company reported net income of
$1.9 million
, or
$0.19
earnings per share, basic and diluted for the second quarter of fiscal year
2019
, compared to a net loss of
$8.1 million
, or an
$0.82
loss per share, basic and diluted, for the second quarter of fiscal year
2018
.
Segment Information
The Company has two reportable segments - Manufacturing and Design Services ("MDS") and Engineered Components and Products ("ECP").
MDS
MDS segment operations are comprised of contract design, manufacturing and aftermarket repair and refurbishment of sophisticated printed circuit card assemblies, sub-assemblies, full product assemblies and cable/wire harnesses for customers seeking to bring their intellectual property to market. Additionally, Sparton is a developer of embedded software and software quality assurance services in connection with medical devices and diagnostic equipment. Customers include OEM and ET customers serving the Medical & Biotechnology, Military & Aerospace and Industrial & Commercial markets. In engineering and manufacturing for its customers, this segment adheres to very strict military and aerospace specifications, Food and Drug Administration guidelines and approvals, in addition to product and process certifications.
ECP
ECP segment operations are comprised of design, development and production of proprietary products for both domestic and foreign defense as well as commercial needs. Sparton designs and manufactures anti-submarine warfare ("ASW") devices known as sonobuoys for the U.S. Navy and foreign governments that meet Department of State licensing requirements. This segment also performs an engineering development function for the United States military and prime defense contractors for advanced technologies, ultimately leading to future defense products, as well as replacements for existing products. The sonobuoy product line is built to stringent military specifications. These products are restricted by International Tariff and Arms Regulations and qualified by the U.S. Navy, which limits opportunities for competition. This segment is also a provider of rugged flat panel display systems for military panel PC workstations, air traffic control and industrial and commercial marine applications, as well as high performance industrial grade computer systems and peripherals. Rugged displays are manufactured for prime contractors, in some cases to specific military grade specifications. Additionally, this segment internally develops and markets commercial products for underwater acoustics and microelectromechanical (“MEMS”)-based inertial measurement.
MDS
The following table presents selected segment data (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Second Quarter of Fiscal Years
|
|
2019
|
|
% of Sales
|
|
2018
|
|
% of Sales
|
|
$ Chg
|
Gross sales
|
$
|
65,402
|
|
|
100.0
|
%
|
|
$
|
58,353
|
|
|
100.0
|
%
|
|
$
|
7,049
|
|
Intercompany sales
|
(3,137
|
)
|
|
(4.8
|
)
|
|
(2,970
|
)
|
|
(5.1
|
)
|
|
(167
|
)
|
Net sales
|
62,265
|
|
|
95.2
|
|
|
55,383
|
|
|
94.9
|
|
|
6,882
|
|
Gross profit
|
8,855
|
|
|
13.5
|
|
|
6,960
|
|
|
11.9
|
|
|
1,895
|
|
Selling and administrative expenses
|
5,758
|
|
|
8.8
|
|
|
5,614
|
|
|
9.6
|
|
|
144
|
|
Amortization of intangible assets
|
1,351
|
|
|
2.0
|
|
|
1,554
|
|
|
2.7
|
|
|
(203
|
)
|
Operating income (loss)
|
$
|
1,746
|
|
|
2.7
|
%
|
|
$
|
(208
|
)
|
|
(0.4
|
)%
|
|
$
|
1,954
|
|
The
$6.9 million
increase in net sales was due to net volume increases with existing customers. MDS backlog was
$153.9 million
at the end of the second quarter of fiscal year
2019
compared to
$142.1 million
at the end of the second quarter of fiscal year 2018. Commercial orders, in general, may be rescheduled or canceled without significant penalty, and as a result, may not be a meaningful measure of future sales. A majority of the
December 30, 2018
MDS backlog is currently expected to be realized in the next
12
months.
Gross profit and gross margin percentage increased primarily due to the increase in net sales while containing labor and overhead spending.
Selling and administrative expense remained consistent period over period.
ECP
The following table presents selected segment data (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Second Quarter of Fiscal Years
|
|
2019
|
|
% of Sales
|
|
2018
|
|
% of Sales
|
|
$ Chg
|
Gross sales
|
$
|
42,983
|
|
|
100.0
|
%
|
|
$
|
42,468
|
|
|
100.0
|
%
|
|
$
|
515
|
|
Intercompany sales
|
—
|
|
|
—
|
|
|
(32
|
)
|
|
(0.1
|
)
|
|
32
|
|
Net sales
|
42,983
|
|
|
100.0
|
|
|
42,436
|
|
|
99.9
|
|
|
547
|
|
Gross profit
|
14,217
|
|
|
33.1
|
|
|
14,789
|
|
|
34.8
|
|
|
(572
|
)
|
Selling and administrative expenses
|
3,497
|
|
|
8.1
|
|
|
3,570
|
|
|
8.4
|
|
|
(73
|
)
|
Internal research and development expenses
|
1,442
|
|
|
3.4
|
|
|
669
|
|
|
1.6
|
|
|
773
|
|
Amortization of intangible assets
|
290
|
|
|
0.7
|
|
|
339
|
|
|
0.8
|
|
|
(49
|
)
|
Operating income
|
$
|
8,988
|
|
|
20.9
|
%
|
|
$
|
10,211
|
|
|
24.0
|
%
|
|
$
|
(1,223
|
)
|
The
$0.5 million
increase in net sales was due to a
$3.5 million
increase in foreign sonobuoy sales and increased engineering sales of
$0.7 million
, offset by a
$2.9 million
decrease in domestic sonobuoy sales and an
$0.8 million
decrease in rugged electronics sales and other revenue streams. Total sales to the U.S. Navy in the second quarter of fiscal years
2019
and
2018
were
$27.9 million
and
$30.1 million
, respectively. For the second quarter of fiscal years
2019
and
2018
, sales to the U.S. Navy accounted for
27%
and
31%
, respectively, of consolidated Company net sales and
65%
and
71%
, respectively, of ECP segment net sales. ECP backlog was
$144.0 million
at the end of the second quarter of fiscal year
2019
compared to
$130.2 million
at the end of the second quarter of fiscal year
2018
. Substantially all of the
December 30, 2018
ECP backlog is currently expected to be realized in the next
18
months.
Gross profit and gross margin percentage decreased from the prior year due to an increase in engineering staff in support of customer programs that is expected to broaden product offerings, partially offset by other overhead cost reductions.
Selling and administrative expense remained consistent period over period.
Internal research and development expenses reflect costs incurred for the internal development of technologies for use in undersea warfare, navigation, hand-held targeting applications as well as rugged electronics and display devices. These costs include salaries and related expenses, contract labor and consulting costs, materials and the cost of certain research and development specific equipment. In the second quarter of fiscal year 2019, ECP increased internal research and development spending, primarily toward technologies in undersea warfare, by
$0.8 million
as compared to the same period in fiscal year 2018.
Eliminations and Corporate Unallocated
The following table presents selected data (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Second Quarter of Fiscal Years
|
|
2019
|
|
2018
|
|
$ Chg
|
Intercompany sales elimination
|
$
|
(3,137
|
)
|
|
$
|
(3,002
|
)
|
|
$
|
(135
|
)
|
Selling and administrative expenses unallocated
|
5,479
|
|
|
4,890
|
|
|
589
|
|
Total corporate selling and administrative expenses before allocation to operating segments were
$8.9 million
and
$8.0 million
for the second quarter of fiscal year
2019
and fiscal year
2018
, respectively, or
8.5%
and
8.2%
of consolidated sales, respectively. Of these costs,
$3.5 million
and
$3.1 million
, respectively, were allocated to segment operations in each of these periods. The increase in corporate selling and administrative expenses was principally due to higher advisory and legal expenses related to the potential sale of the Company.
For the First Two Quarters of Fiscal Year 2019 compared to the First Two Quarters of Fiscal Year 2018
The following table presents selected consolidated statement of operations data (dollars in thousands):
CONSOLIDATED
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the First Two Quarters of Fiscal Years
|
|
2019
|
|
% of Sales
|
|
2018
|
|
% of Sales
|
Net sales
|
$
|
194,710
|
|
|
100.0
|
%
|
|
$
|
180,582
|
|
|
100.0
|
%
|
Cost of goods sold
|
153,999
|
|
|
79.1
|
|
|
142,909
|
|
|
79.1
|
|
Gross profit
|
40,711
|
|
|
20.9
|
|
|
37,673
|
|
|
20.9
|
|
Selling and administrative expenses
|
27,104
|
|
|
13.9
|
|
|
29,279
|
|
|
16.2
|
|
Internal research and development expenses
|
2,791
|
|
|
1.4
|
|
|
1,241
|
|
|
0.7
|
|
Amortization of intangible assets
|
3,311
|
|
|
1.7
|
|
|
3,816
|
|
|
2.2
|
|
Operating income
|
7,505
|
|
|
3.9
|
|
|
3,337
|
|
|
1.8
|
|
Other expense, net
|
(3,810
|
)
|
|
(2.0
|
)
|
|
(2,770
|
)
|
|
(1.5
|
)
|
Income before income taxes
|
3,695
|
|
|
1.9
|
|
|
567
|
|
|
0.3
|
|
Income taxes
|
1,566
|
|
|
0.8
|
|
|
10,635
|
|
|
5.9
|
|
Net income (loss)
|
$
|
2,129
|
|
|
1.1
|
%
|
|
$
|
(10,068
|
)
|
|
(5.6
|
)%
|
The $14.1 million increase in net sales was the result of a $10.6 million increase in our MDS segment and
$3.5 million
increase in our ECP segment, principally attributable to volume.
The increase in gross profit was primarily attributable to the increase in sales volume while consolidated gross margin was flat. The MDS segment realized a more favorable product mix and containment of labor and overhead expenses, partially offset by increased overhead expenses within the ECP segment arising from an increase in engineering staff in support of additional customer programs.
Selling and administrative expenses decreased due to lower legal and advisory expenses related to the potential sale of the Company and a decrease in compensation associated with performance-based bonuses.
As previously addressed in the results of operations in the second quarter of fiscal years 2019 and 2018, the implementation of the Tax Act had a significant impact on the Company's income tax provision in the first two quarters of fiscal year 2018. Excluding the impact of discrete tax events, including the initial recognition on the Company's income tax provision due to the upon implementation of the Tax Act and other matters previously disclosed, the Company's estimated annual effective income tax rates for fiscal years 2019 and 2018 were determined to be approximately 21% and 28%, respectively.
Due to the factors described above, the Company reported net income of
$2.1 million
, or
$0.22
earnings per share, basic and diluted, for the first two quarters of fiscal year 2019, compared to a net loss of
$10.1 million
, or a
$1.02
loss per share, basic and diluted, for the first two quarters of fiscal year 2018.
MDS
The following table presents selected segment data (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the First Two Quarters of Fiscal Years
|
|
2019
|
|
% of Sales
|
|
2018
|
|
% of Sales
|
|
$ Chg
|
Gross sales
|
$
|
124,696
|
|
|
100.0
|
%
|
|
$
|
113,661
|
|
|
100.0
|
%
|
|
$
|
11,035
|
|
Intercompany sales
|
(6,281
|
)
|
|
(5.0
|
)
|
|
(5,907
|
)
|
|
(5.2
|
)
|
|
(374
|
)
|
Net sales
|
118,415
|
|
|
95.0
|
|
|
107,754
|
|
|
94.8
|
|
|
10,661
|
|
Gross profit
|
16,064
|
|
|
12.9
|
|
|
12,953
|
|
|
11.4
|
|
|
3,111
|
|
Selling and administrative expenses
|
11,302
|
|
|
9.1
|
|
|
11,514
|
|
|
10.1
|
|
|
(212
|
)
|
Amortization of intangible assets
|
2,726
|
|
|
2.2
|
|
|
3,132
|
|
|
2.8
|
|
|
(406
|
)
|
Operating income (loss)
|
$
|
2,036
|
|
|
1.6
|
%
|
|
$
|
(1,693
|
)
|
|
(1.5
|
)%
|
|
$
|
3,729
|
|
The $10.6 million increase in net sales was principally due to volume increases with existing customers across multiple locations. Gross profit increased
$3.1 million
principally attributable to the increased sales volume, as total costs of sales components remained constant.
Selling and administrative expenses were essentially flat.
ECP
The following table presents selected segment data (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the First Two Quarters of Fiscal Years
|
|
2019
|
|
% of Sales
|
|
2018
|
|
% of Sales
|
|
$ Chg
|
Gross sales
|
$
|
76,295
|
|
|
100.0
|
%
|
|
$
|
72,867
|
|
|
100.0
|
%
|
|
$
|
3,428
|
|
Intercompany sales
|
—
|
|
|
—
|
|
|
(39
|
)
|
|
(0.1
|
)
|
|
39
|
|
Net sales
|
76,295
|
|
|
100.0
|
|
|
72,828
|
|
|
99.9
|
|
|
3,467
|
|
Gross profit
|
24,647
|
|
|
32.3
|
|
|
24,720
|
|
|
33.9
|
|
|
(73
|
)
|
Selling and administrative expenses
|
7,180
|
|
|
9.4
|
|
|
7,150
|
|
|
9.8
|
|
|
30
|
|
Internal research and development expenses
|
2,791
|
|
|
3.7
|
|
|
1,241
|
|
|
1.7
|
|
|
1,550
|
|
Amortization of intangible assets
|
585
|
|
|
0.8
|
|
|
684
|
|
|
0.9
|
|
|
(99
|
)
|
Operating income
|
$
|
14,091
|
|
|
18.4
|
%
|
|
$
|
15,645
|
|
|
21.5
|
%
|
|
$
|
(1,554
|
)
|
The increase in net sales of
$3.5 million
was due to a (i)
$2.3 million
increase in engineering services, (ii)
$1.0 million
increase in domestic sonobuoy sales, and a (iii)
$1.1 million
increase in foreign sonobuoy sales, the sum of which was partially offset by a
$0.9 million
decrease in rugged electronics revenue. Total sales to the U.S. Navy in the first two quarters of fiscal years 2019 and 2018 were approximately
$50.9 million
and $47.7 million, respectively. For the first two quarters of fiscal years 2019 and 2018, sales to the U.S. Navy accounted for
26%
and
26%
, respectively, of consolidated Company net sales and
67%
and
65%
, respectively, of ECP segment net sales.
Gross profit and gross margin percentage decreased from the prior year due to an increase in engineering staff in support of customer programs expected to broaden product offerings, partially offset by other overhead cost reductions.
Selling and administrative expense remained consistent period over period.
In the first two quarters of fiscal year 2019, internal research and development spending, primarily toward technologies in undersea warfare, increased
$1.6 million
as compared to the same period in fiscal year 2018.
Eliminations and Corporate Unallocated
The following table presents selected consolidated statement of income data (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the First Two Quarters of Fiscal Years
|
|
2019
|
|
2018
|
|
$ Chg
|
Intercompany sales elimination
|
$
|
(6,281
|
)
|
|
$
|
(5,946
|
)
|
|
$
|
(335
|
)
|
Selling and administrative expenses unallocated
|
8,622
|
|
|
10,615
|
|
|
(1,993
|
)
|
Total corporate selling and administrative expenses before allocation to operating segments were
$15.4 million
and
$17.2 million
for the first two quarters of fiscal year 2019 and fiscal year 2018, respectively, or
7.9%
and
9.5%
of consolidated net sales, respectively. Of these costs,
$6.8 million
and
$6.6 million
, respectively, were allocated to segment operations in each of these periods. Selling and administrative expense decreased to lower legal and advisory expenses related to the potential sale of the Company and a decrease in compensation associated with performance-based bonuses.
Liquidity and Capital Resources
As of
December 30, 2018
, the Company had
$49.8 million
available under its
$120.0 million
credit facility, with current borrowings under the facility of
$64.1 million
and outstanding letters of credit of
$6.0 million
.
On September 11, 2014, the Company entered into a revolving line-of-credit facility with a group of banks (the “Credit Facility”) which expires on September 11, 2019. On May 3, 2018, the Company entered into Amendment No.5 ("Amendment 5") to the Credit Facility. Under the terms of Amendment 5, (i) the revolving credit facility was reduced from
$125.0 million
to
$120.0 million
, (ii) the Company's permitted Total Funded Debt to EBITDA Ratio, as defined, was increased to 4.5x for the fiscal quarters ended April 1, 2018 and July 1, 2018, and beginning with the fiscal quarters ended September 30, 2018 and thereafter, the Company's permitted Total Funded Debt to EBITDA Ratio was decreased to 3.0x, and (iii) the interest rates on the revolving line of credit were increased, at the Company's option, to either LIBOR, plus
3.50%
to
4.50%
, or the bank’s base rate, as defined, plus
2.50%
to
3.50%
. In addition, Amendment 5 also fixed the commitment fees on the unused portion of the Credit Facility at
0.50%
.
The Credit Facility is secured by substantially all assets of the Company and its subsidiaries.
The Credit Facility includes representations, covenants and events of default that are customary for financing transactions of this nature. The Company was in compliance with all covenants at
December 30, 2018
.
As a result of the pending acquisition of the Company and the full repayment of the Credit Facility upon the effective date of the Merger, the Credit Facility has been classified as a current liability on the Company's consolidated balance sheet as of December 30, 2018.
|
|
|
|
|
|
|
|
|
|
For the First Two Quarters of Fiscal Years
|
CASH FLOWS
|
2019
|
|
2018
|
Operating activities, excluding net changes in working capital
|
$
|
11,989
|
|
|
$
|
7,709
|
|
Net changes in working capital
|
10,724
|
|
|
(8,583
|
)
|
Operating activities
|
22,713
|
|
|
(874
|
)
|
Investing activities
|
(1,953
|
)
|
|
(3,085
|
)
|
Financing activities
|
(20,535
|
)
|
|
4,075
|
|
Net changes in working capital related cash flows in the first two quarters of fiscal year 2019 primarily reflect decreased accounts receivables and prepaid expenses and other assets, and increased accounts payable and accrued expenses, which were partially offset by increased inventories and increased performance based payments on customer contracts. Working capital related cash flows in the first two quarters of fiscal year 2018 primarily reflect increased accounts receivables and inventories as well as reduced performance based payments, which were partially offset by increased accounts payable and accrued expenses.
Net cash used in investing activity for the first two quarters of fiscal year
2019
and
2018
reflect net capital expenditures of
$2.0 million
and
$3.1 million
, respectively.
Net cash used in financing activities in the first two quarters of fiscal year
2019
was principally attributable to
$20.4 million
of net repayments under the Company's Credit Facility as compared to net cash provided by financing activities principally arising from
$4.4 million
in net borrowings for the first two quarters of fiscal year
2018
.
Commitments and Contingencies
See Note 9, Commitments and Contingencies, of the “Notes to Unaudited Consolidated Financial Statements” in this Quarterly Report on Form 10-Q for a discussion of the Company's commitments and contingencies.
Contractual Obligations
Information regarding the Company’s long-term debt obligations, environmental liability payments, operating lease payments and other commitments is provided in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” of the Company’s Annual Report on Form 10-K for fiscal year ended
July 1, 2018
. As of
July 1, 2018
, there were
$51.0 million
of non-cancelable purchase orders outstanding,
$84.5 million
of debt,
$12.3 million
of operating lease payments and a liability related to performance based billings was
$3.9 million
. As of
December 30, 2018
, the non-cancelable purchase orders outstanding increased to
$51.8 million
, debt decreased to
$64.1 million
, operating lease payments, net of subleases, decreased to
$11.1 million
and a liability related to performance based billings increased to
$8.8 million
. Other than as noted above, there have been no material changes in the nature or amount of the Company’s contractual obligations since the end of fiscal year
2018
.
Off-Balance Sheet Arrangements
The Company has standby letters of credit outstanding of
$6.0 million
at
December 30, 2018
, principally to support foreign sonobuoy sales, insurance arrangements, and an environmental remediation matter as required in connection with the EPA's financial assurance requirements, as disclosed in Note 9, Commitments and Contingencies, of the "Notes to Unaudited Consolidated Financial Statements" in this Quarterly Report on Form 10-Q. Other than these standby letters of credit and the operating lease commitments referenced above, we have no off-balance sheet arrangements that would have a current or future material effect on our financial condition, changes in financial condition, revenue, expense, results of operations, liquidity, capital expenditures or capital resources.
Critical Accounting Policies
Our financial statements are prepared in conformity with GAAP and require us to select appropriate accounting policies. The assumptions and judgments we use in applying our accounting policies have a significant impact on our reported amounts of assets, liabilities, revenue and expenses. While we believe that the assumptions and judgments used in our estimates are reasonable, actual results may differ from these estimates under different assumptions or conditions.
We have identified the most critical accounting policies upon which our financial status depends. The critical policies were determined by considering accounting policies that involve the most complex or subjective decisions or assessments. We also have other policies considered key accounting policies; however, these policies do not meet the definition of critical accounting policies because they do not generally require us to make estimates or judgments that are complex or subjective.
Our critical accounting policies include the following:
•
Revenue recognition
•
Goodwill and other intangible assets
•
Environmental contingencies
•
Income taxes
•
Commercial inventory valuation
•
Stock-based compensation
Except as disclosed in Note 2, Revenue Recognition, and Note 13, New Accounting Standards, of the “Notes to Unaudited Consolidated Financial Statements," there have been no significant changes to our critical accounting policies described in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section of our Annual Report on Form 10-K for the fiscal year ended
July 1, 2018
.
New Accounting Pronouncements
See Note 13, New Accounting Standards, of the “Notes to Unaudited Consolidated Financial Statements” in this Quarterly Report on Form 10-Q for a discussion of new accounting pronouncements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
The Company manufactures its products in the United States, Canada and Vietnam. Sales of the Company’s products are in the U.S. and foreign markets. The Company is subject to foreign currency exchange rate risk relating to intercompany activity and balances and to receipts from customers and payments to suppliers in foreign currencies. Adjustments related to the remeasurement of the Company's Canadian and Vietnamese financial statements into U.S. dollars are included in current earnings. As a result, the Company's financial results could be affected by factors such as changes in foreign currency exchange rates or economic conditions in the domestic and foreign markets in which the Company operates. However, minimal third party receivables and payables are denominated in foreign currencies and the related market risk exposure is considered to be immaterial.
The Company’s revolving credit line, when drawn upon, is subject to future interest rate fluctuations which could potentially have a negative impact on cash flows of the Company. The Company had
$64.1 million
outstanding under its Credit Facility at
December 30, 2018
. A prospective increase of 100 basis points in the interest rate applicable to the Company’s outstanding borrowings under its Credit Facility would result in an increase of
$0.6 million
in our annual interest expense. The Company is not party to any currency exchange or interest rate protection agreements as of
December 30, 2018
.
Item 4. Controls and Procedures.
Our Interim Chief Executive Officer and our Chief Financial Officer each has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange
Act of 1934) as of the end of the period covered by this quarterly report. Based on such evaluation, such officers have concluded that, as of the end of the period covered by this quarterly report, our disclosure controls and procedures are effective.
Remediation of prior year material weaknesses
We previously identified and disclosed in our Form 10-K for the year ended July 1, 2018, a material weakness in our internal control over financial reporting, as we did not maintain effective controls related to the use of our consolidation and financial reporting tool in our interim reporting periods within the above year.
As part of our financial statement close process for fiscal year 2018 and for the first six months of fiscal 2019, we implemented changes to our processes to improve our controls over financial reporting. Among the changes implemented as a result of the identified material weakness, we no longer allow adjustments to be made in our consolidation and financial reporting tool (other than reclassification entries for reporting purposes) that are not also reflected in the ERP systems of the operating entities, and we have increased our oversight of the consolidation and reporting tool. Based on the remediation performed by us, we have concluded that the material weakness described above and first disclosed in our Annual Report on Form 10-K for the year ended July 1, 2018 has been remediated as of September 30, 2018.
Changes in Internal Control over Financial Reporting
In addition to the changes described above to remediate the previously identified material weakness, we adopted ASC 606, “Revenue from Contracts with Customers” (“ASC 606”), as of
July 2, 2018
, and as a result, there was an impact to our internal control over financial reporting. The majority of our ECP revenue changed from being recognized on a percentage of completion based on units shipped methodology to a point in time upon shipment methodology. We implemented changes to our processes related to revenue recognition and control activities within them. These changes included the development of new and revised processes based on the five-step model provided in ASC 606, and the revision of processes for ongoing contract review requirements, development and monitoring of contract estimates, and gathering of disclosure information.